The Experts below are selected from a list of 258 Experts worldwide ranked by ideXlab platform

M E K Wahba - One of the best experts on this subject based on the ideXlab platform.

  • analysis of clozapine in its tablets using two novel spectrophotometric reactions targeting its Tertiary Amino Group
    Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2020
    Co-Authors: Aya Ayman, Abdallah M Zeid, M E K Wahba, Yasser Elshabrawy
    Abstract:

    Abstract Two simple spectrophotometric methodologies have been proposed and validated for the measurement of an atypical antipsychotic drug Clozapine (CLZ). Method A depends on interaction of CLZ with N-bromosuccinimide(NBS) resulting in formation of a yellowish orange colored product, measured at 320 nm. The linearity range was 5.0–70.0 μg/mL. Method B depends on condensation of the same drug with acetic acid mixed anhydride reagent producing a purple colored product, measured at 319 nm. The linearity range was 8.0–24.0 μg/mL. All parameters affecting the reaction condition (volume of both reagent, temperature, time and the different diluting solvents) were optimized. Both methods were successfully applied to assay CLZ in its pure form and tablets giving mean percentage recoveries of (98.87 ± 1.8 and 100 ± 1.7) for method A, and corresponding values of (98.6 ± 0.96 and 99.5 ± 1) for method B. Besides, the study of reactions stoichiometry was performed and the reaction mechanisms were proposed.

  • validated stability indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations
    Chemistry Central Journal, 2011
    Co-Authors: Fawzia Ibrahim, Mohie Sharaf K Eldin, Manal Eid, M E K Wahba
    Abstract:

    Two sensitive, selective, economic, and validated spectrofluorimetric methods were developed for the determination of ebastine (EBS) in pharmaceutical preparations depending on reaction with its Tertiary Amino Group. Method I involves condensation of the drug with mixed anhydrides (citric and acetic anhydrides) producing a product with intense fluorescence, which was measured at 496 nm after excitation at 388 nm. Method (IIA) describes quantitative fluorescence quenching of eosin upon addition of the studied drug where the decrease in the fluorescence intensity was directly proportional to the concentration of ebastine; the fluorescence quenching was measured at 553 nm after excitation at 457 nm. This method was extended to (Method IIB) to apply first and second derivative synchronous spectrofluorimetric method (FDSFS & SDSFS) for the simultaneous analysis of EBS in presence of its alkaline, acidic, and UV degradation products. The proposed methods were successfully applied for the determination of the studied compound in its dosage forms. The results obtained were in good agreement with those obtained by a comparison method. Both methods were utilized to investigate the kinetics of the degradation of the drug.

Chuchi Tang - One of the best experts on this subject based on the ideXlab platform.

Yoshiji Takemoto - One of the best experts on this subject based on the ideXlab platform.

Peng Gao - One of the best experts on this subject based on the ideXlab platform.

Fawzia Ibrahim - One of the best experts on this subject based on the ideXlab platform.

  • Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations
    Chemistry Central Journal, 2011
    Co-Authors: Fawzia Ibrahim, Mary Elias Kamel Wahba
    Abstract:

    Two sensitive, selective, economic, and validated spectrofluorimetric methods were developed for the determination of ebastine (EBS) in pharmaceutical preparations depending on reaction with its Tertiary Amino Group. Method I involves condensation of the drug with mixed anhydrides (citric and acetic anhydrides) producing a product with intense fluorescence, which was measured at 496 nm after excitation at 388 nm. Method (IIA) describes quantitative fluorescence quenching of eosin upon addition of the studied drug where the decrease in the fluorescence intensity was directly proportional to the concentration of ebastine; the fluorescence quenching was measured at 553 nm after excitation at 457 nm. This method was extended to (Method IIB) to apply first and second derivative synchronous spectrofluorimetric method (FDSFS & SDSFS) for the simultaneous analysis of EBS in presence of its alkaline, acidic, and UV degradation products. The proposed methods were successfully applied for the determination of the studied compound in its dosage forms. The results obtained were in good agreement with those obtained by a comparison method. Both methods were utilized to investigate the kinetics of the degradation of the drug.

  • validated stability indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations
    Chemistry Central Journal, 2011
    Co-Authors: Fawzia Ibrahim, Mohie Sharaf K Eldin, Manal Eid, M E K Wahba
    Abstract:

    Two sensitive, selective, economic, and validated spectrofluorimetric methods were developed for the determination of ebastine (EBS) in pharmaceutical preparations depending on reaction with its Tertiary Amino Group. Method I involves condensation of the drug with mixed anhydrides (citric and acetic anhydrides) producing a product with intense fluorescence, which was measured at 496 nm after excitation at 388 nm. Method (IIA) describes quantitative fluorescence quenching of eosin upon addition of the studied drug where the decrease in the fluorescence intensity was directly proportional to the concentration of ebastine; the fluorescence quenching was measured at 553 nm after excitation at 457 nm. This method was extended to (Method IIB) to apply first and second derivative synchronous spectrofluorimetric method (FDSFS & SDSFS) for the simultaneous analysis of EBS in presence of its alkaline, acidic, and UV degradation products. The proposed methods were successfully applied for the determination of the studied compound in its dosage forms. The results obtained were in good agreement with those obtained by a comparison method. Both methods were utilized to investigate the kinetics of the degradation of the drug.